Leptin has also been highlighted as a functional risk factor because the presence of this macromolecule worsens OSA and has been demonstrated to affect sleep architecture, particularly in patients with hypertension [30, 34], as it affects satiety, glucose levels, and fatty acid metabolism. This evidence concerns the gene LEP and obstructive sleep apnea syndrome.